{"id":254,"date":"2014-01-29T16:35:34","date_gmt":"2014-01-29T14:35:34","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/"},"modified":"2026-10-06T06:29:22","modified_gmt":"2026-10-06T03:29:22","slug":"pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/","title":{"rendered":"&#8220;Pfizer&#8221; pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>ASV farm\u0101cijas uz\u0146\u0113mums &#8220;Pfizer&#8221; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA.<\/p>\n<p>Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu p\u0101rdo\u0161anas. Uz\u0146\u0113muma pe\u013c\u0146a gan veido 0,56 dol\u0101rus uz vienu akciju, t\u0101d\u0113j\u0101di par 0,04 dol\u0101riem p\u0101rsniedzot anal\u012bti\u0137u prognozes, zi\u0146o LETA.<\/p>\n<p>Tikm\u0113r &#8220;Pfizer&#8221; apgroz\u012bjums iepriek\u0161\u0113j\u0101 ceturksn\u012b samazin\u0101jies par 2,4% &#8211; l\u012bdz 13,6 miljardiem dol\u0101ru (9,9 miljardiem eiro).<\/p>\n<p>Savuk\u0101rt p\u0113rn kopum\u0101 &#8220;Pfizer&#8221; pe\u013c\u0146a palielin\u0101jusies par 51% un veidojusi 22 miljardus dol\u0101ru (16,1 miljardu eiro).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ASV farm\u0101cijas uz\u0146\u0113mums &#8220;Pfizer&#8221; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11790,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[9,70,76,7],"tags":[144],"mic_flag":[],"class_list":["post-254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-arzemes","category-farmacijas-zinas","category-jaunakie-raksti","category-statistika","tag-pfizer"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"ASV farm\u0101cijas uz\u0146\u0113mums &quot;Pfizer&quot; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"ASV farm\u0101cijas uz\u0146\u0113mums &quot;Pfizer&quot; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif\" \/>\n\t\t<meta property=\"og:image:width\" content=\"574\" \/>\n\t\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-01-29T14:35:34+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:22+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"ASV farm\u0101cijas uz\u0146\u0113mums &quot;Pfizer&quot; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"position\":2,\"name\":\"Statistika\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#listItem\",\"name\":\"&#8220;Pfizer&#8221; pe\\u013c\\u0146a ceturtaj\\u0101 ceturksn\\u012b sarukusi par 59,3%\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#listItem\",\"position\":3,\"name\":\"&#8220;Pfizer&#8221; pe\\u013c\\u0146a ceturtaj\\u0101 ceturksn\\u012b sarukusi par 59,3%\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#newsarticle\",\"name\":\"\\u201cPfizer\\u201d pe\\u013c\\u0146a ceturtaj\\u0101 ceturksn\\u012b sarukusi par 59,3% - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;Pfizer&#8221; pe\\u013c\\u0146a ceturtaj\\u0101 ceturksn\\u012b sarukusi par 59,3%\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/pfizer.gif\",\"width\":574,\"height\":360},\"datePublished\":\"2014-01-29T16:35:34+02:00\",\"dateModified\":\"2026-10-06T06:29:22+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#webpage\"},\"articleSection\":\"\\u0100rzem\\u0113s, Farm\\u0101cija, Jaun\\u0101kie raksti, Statistika, Pfizer\",\"dateline\":\"Published on January 29, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/\",\"name\":\"\\u201cPfizer\\u201d pe\\u013c\\u0146a ceturtaj\\u0101 ceturksn\\u012b sarukusi par 59,3% - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"ASV farm\\u0101cijas uz\\u0146\\u0113mums \\\"Pfizer\\\" p\\u0113rn\\u0101 gada ceturtaj\\u0101 ceturksn\\u012b str\\u0101d\\u0101ja ar 2,6 miljardu dol\\u0101ru (1,9 miljardu eiro) t\\u012bro pe\\u013c\\u0146u, kas ir par 59,3% maz\\u0101k nek\\u0101 attiec\\u012bgaj\\u0101 laika period\\u0101 2012.gad\\u0101, balstoties uz uz\\u0146\\u0113muma publiskoto pazi\\u0146ojumu, raksta zi\\u0146u a\\u0123ent\\u016bra LETA. Pe\\u013c\\u0146as kritums galvenok\\u0101rt tiek skaidrots ar augsto sal\\u012bdzin\\u0101juma b\\u0101zi 2012.gada attiec\\u012bgaj\\u0101 ceturksn\\u012b, kad firma guva ien\\u0101kumus no akt\\u012bvu\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/pfizer.gif\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#mainImage\",\"width\":574,\"height\":360},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\\\/#mainImage\"},\"datePublished\":\"2014-01-29T16:35:34+02:00\",\"dateModified\":\"2026-10-06T06:29:22+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs","description":"ASV farm\u0101cijas uz\u0146\u0113mums \"Pfizer\" p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu","canonical_url":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","position":2,"name":"Statistika","item":"https:\/\/farmacija-mic.lv\/category\/statistika\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#listItem","name":"&#8220;Pfizer&#8221; pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#listItem","position":3,"name":"&#8220;Pfizer&#8221; pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#newsarticle","name":"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;Pfizer&#8221; pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif","width":574,"height":360},"datePublished":"2014-01-29T16:35:34+02:00","dateModified":"2026-10-06T06:29:22+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#webpage"},"articleSection":"\u0100rzem\u0113s, Farm\u0101cija, Jaun\u0101kie raksti, Statistika, Pfizer","dateline":"Published on January 29, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/","name":"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs","description":"ASV farm\u0101cijas uz\u0146\u0113mums \"Pfizer\" p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif","@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#mainImage","width":574,"height":360},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/#mainImage"},"datePublished":"2014-01-29T16:35:34+02:00","dateModified":"2026-10-06T06:29:22+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs","og:description":"ASV farm\u0101cijas uz\u0146\u0113mums &quot;Pfizer&quot; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu","og:url":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif","og:image:width":574,"og:image:height":360,"article:published_time":"2014-01-29T14:35:34+00:00","article:modified_time":"2026-10-06T03:29:22+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3% - Medikamentu Inform\u0101cijas Centrs","twitter:description":"ASV farm\u0101cijas uz\u0146\u0113mums &quot;Pfizer&quot; p\u0113rn\u0101 gada ceturtaj\u0101 ceturksn\u012b str\u0101d\u0101ja ar 2,6 miljardu dol\u0101ru (1,9 miljardu eiro) t\u012bro pe\u013c\u0146u, kas ir par 59,3% maz\u0101k nek\u0101 attiec\u012bgaj\u0101 laika period\u0101 2012.gad\u0101, balstoties uz uz\u0146\u0113muma publiskoto pazi\u0146ojumu, raksta zi\u0146u a\u0123ent\u016bra LETA. Pe\u013c\u0146as kritums galvenok\u0101rt tiek skaidrots ar augsto sal\u012bdzin\u0101juma b\u0101zi 2012.gada attiec\u012bgaj\u0101 ceturksn\u012b, kad firma guva ien\u0101kumus no akt\u012bvu","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pfizer.gif"},"aioseo_meta_data":{"post_id":"254","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-22 18:16:28","updated":"2026-10-07 10:40:14"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/statistika\/\" title=\"Statistika\">Statistika<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cPfizer\u201d pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Statistika","link":"https:\/\/farmacija-mic.lv\/category\/statistika\/"},{"label":"&#8220;Pfizer&#8221; pe\u013c\u0146a ceturtaj\u0101 ceturksn\u012b sarukusi par 59,3%","link":"https:\/\/farmacija-mic.lv\/en\/pfizer-pelna-ceturtaja-ceturksni-sarukusi-par-593\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=254"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/254\/revisions"}],"predecessor-version":[{"id":1986,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/254\/revisions\/1986"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/11790"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=254"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}